Galychpharm PJSC (UKEX:GFARM) Shareholder Yield % : 0.00% (As of . 20)


UKEX:GFARM Galychpharm PJSC UKEX:GFARM
14 GF Score
Price ₴100.00
! 1 Warning Sign
View Full Analysis

What is Galychpharm PJSC Shareholder Yield %?

Galychpharm PJSC UKEX:GFARM 14 Shareholder Yield % is 0.00% as of . 20. GuruFocus rates UKEX:GFARM with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. Galychpharm PJSC does not have enough data to calculate Shareholder Yield %.


Galychpharm PJSC  (UKEX:GFARM) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Galychpharm PJSC Shareholder Yield % Related Terms


Galychpharm PJSC Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Galychpharm PJSC's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galychpharm PJSC Shareholder Yield % Chart

Galychpharm PJSC Annual Data
Trend
Shareholder Yield %

Galychpharm PJSC Semi-Annual Data
Shareholder Yield %

UKEX:GFARM vs HSTC, STLT, NTRR: Shareholder Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Galychpharm PJSC's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galychpharm PJSC Shareholder Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galychpharm PJSC's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Galychpharm PJSC's Shareholder Yield % falls into.


UKEX:GFARM
14GF Score
Galychpharm PJSC UKEX:GFARM
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galychpharm PJSC Shareholder Yield % Calculation

Galychpharm PJSC's Shareholder Yield % for the quarter that ended in . 20 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
= %+ %+ %
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 0.00% mean?
Galychpharm PJSC (UKEX:GFARM) has a Shareholder Yield % of 0.00% as of . 20. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Galychpharm PJSC and its competitors.
Is Galychpharm PJSC's Shareholder Yield % too high?
Galychpharm PJSC's current Shareholder Yield % is 0.00%. Overall, Galychpharm PJSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Galychpharm PJSC's Shareholder Yield % compare to HSTC and STLT?
Galychpharm PJSC's Shareholder Yield % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Shareholder Yield % is 0.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Drug Manufacturers company?
The median Shareholder Yield % among Drug Manufacturers companies is 0.34, based on 970 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Galychpharm PJSC and its competitors. For the Drug Manufacturers industry, the median Shareholder Yield % is 0.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galychpharm PJSC's current Shareholder Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galychpharm PJSC stock overvalued right now?
Galychpharm PJSC (UKEX:GFARM) has a current Shareholder Yield % of 0.00%. The current Shareholder Yield % is 0.00%. Galychpharm PJSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Galychpharm PJSC (UKEX:GFARM), the current Shareholder Yield % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galychpharm PJSC Business Description

Address 6/8 Opryshkivska Street, Lviv, UKR, 79024
Galychpharm PJSC is engaged in the production and sale of drugs and other medicines. It offers phytochemical substances, crude drugs, injection ampoules, tablets, solutions, extracts, and syrups.
14GF Score

Get the complete analysis for UKEX:GFARM

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴100.00
Price